Abstract:1631 Objectives: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the degeneration of dopaminergic neurons in the substantia nigra of the brain. Stem cell therapy holds great promise as a potential treatment strategy to produce functional neurons from human pluripotent stem cells (PSCs). A strategy of using PSC-derived dopamine neurons modified to express active or inhibitory forms of DREADD (designer receptors exclusively activated by designer drugs) has been developed to evaluate therapeutic potential for PD treatment in the rhesus monkey model. PET radiotracers of [C-11]clozapine and [C-11]raclopride were used to investigate alterations in binding patterns in the endogenous dopamine competition following treatment with the exogenous designer drug clozapine-N-oxide (CNO). Methods: Five rhesus monkeys underwent a unilateral intracarotid artery injection of MPTP targeting the right substantia nigra or putamen. All monkeys received unilateral intracerebral injections of PSCs with guidance from real-time intraoperative magnetic resonance imaging (RT-IMRI) performed in a 3-T GE SIGNA MRI scanner. Daily doses of CNO were administered to the monkeys to activate the DREADDs expressed by the PSC-derived neurons. Four monkeys underwent [C-11]clozapine scans and one monkey underwent a [C-11]raclopride scan on a microPET Focus 220 scanner. Dynamic data were acquired for 90 minutes post-injection of [C-11]clozapine, and a 120 minute bolus+infusion scan of [C-11]raclopride to assess dopamine release during CNO activation. Regions of interest (ROIs) were drawn for the left putamen, right putamen and cerebellum. Time activity curves (TACs) were generated for each ROI for a semi-quantitative comparison of bilateral differences in putamen uptake following treatment. Results: Asymmetries between the left and right putamen were noticed in the PET data for the [C-11]clozapine scans. Two monkeys showed unilateral uptake of radiotracer with no uptake in the right putamen. The remaining showed bilateral uptake of radiotracer in both the left and right putamen following treatment. The [C-11]raclopride results showed bilateral uptake of radiotracer with elevated uptake in the right putamen following the administration of CNO indicating alteration in dopaminergic function. Conclusions: These qualitative results show the potential for evaluation of PSC-derived neuronal function using PET methodologies. The semi-quantitative analysis will be confirmed through histology studies to show the precise location and effectiveness of PSC engraftment at restoring neuronal function.

MicroPET/CT Assessment of FDG Uptake in Brain after Long-Term Methylphenidate Treatment in Nonhuman Primates

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

MicroPET/CT Imaging of [18F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity

Insights from Neuronal and Behavioral Studies in Freely Behaving Rats

Distinct lncRNA expression profiles in the prefrontal cortex of SD rats after exposure to methylphenidate.

Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study

PET Imaging Reveals Brain Metabolic Changes in Adolescent Rats Following Chronic Escalating Morphine Administration

Long-Term Methamphetamine Administration in the Vervet Monkey Models Aspects of a Human Exposure: Brain Neurotoxicity and Behavioral Profiles

Insights from Behavioral and Dorsal Raphe Nucleus Neuronal Recordings from Freely Behaving Rats

Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

Using PET Methods to Evaluate Induced Pluripotent Stem Cell-Derived Neuronal Function

[Effect of Methylphenidate on C-Fos Expression in Parvalbumin Interneurons of Juvenile Rat Frontal Cortex].

Progressive Loss of Striatal Dopamine Terminals in MPTP-induced Acute Parkinsonism in Cynomolgus Monkeys Using Vesicular Monoamine Transporter Type 2 PET Imaging ([ 18 F]AV-133)

[Changes of Glucose in the Brains of Monkeys with MPTP Induced Parkinson's Disease].

Novel pharmacokinetic model to estimate dopamine dynamics in humans using PET

Animal model of methylphenidate's long-term memory-enhancing effects

Methylphenidate Normalizes Resting-State Brain Dysfunction in Boys With Attention Deficit Hyperactivity Disorder

Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)

Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates